Literature DB >> 20888804

Progranulin deficiency leads to enhanced cell vulnerability and TDP-43 translocation in primary neuronal cultures.

Aobo Guo1, Lucia Tapia, Shernaz X Bamji, Max S Cynader, William Jia.   

Abstract

Null mutations in the progranulin gene (PGRN) have been identified as a major cause of frontotemporal dementia with ubiquitinated inclusions. In this disorder, ubiquitinated, aggregated protein inclusions of a normally nuclear-located RNA processing protein called TAR DNA binding protein (TDP-43) accumulate in the neuronal cytoplasm (FTLD-TDP). To determine whether aspects of this clinical pathology can be established in primary cultures of mouse cortical neurons, PGRN levels were knocked down in neuronal cultures using lentiviral vectors to introduce mouse PGRN-siRNA constructs and subsequently rescued by overexpressing PGRN using a human PGRN-expressing lentiviral vector. The depletion of PGRN enhanced caspase-3 activation, and the PGRN-deficient neurons demonstrated enhanced vulnerability to normally sublethal doses of N-methyl-D-aspartic acid (NMDA) and hydrogen peroxide (H(2)O(2)). TDP-43 protein levels were markedly increased in the cytoplasm of PGRN-deficient neurons relative to nuclear levels, which is similar to observations in the brains of FTLD-TDP patients. Our results establish a neuronal culture model of the PGRN deficiency, which displays some of the important phenotypic characteristics of the early stages of the disease. The results further suggest that the seeds of this form of frontotemporal dementia may be sown early in life.
Copyright © 2010. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20888804     DOI: 10.1016/j.brainres.2010.09.099

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  31 in total

1.  Core features of frontotemporal dementia recapitulated in progranulin knockout mice.

Authors:  N Ghoshal; J T Dearborn; D F Wozniak; N J Cairns
Journal:  Neurobiol Dis       Date:  2011-09-10       Impact factor: 5.996

2.  Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.

Authors:  Mariely DeJesus-Hernandez; Ian R Mackenzie; Bradley F Boeve; Adam L Boxer; Matt Baker; Nicola J Rutherford; Alexandra M Nicholson; NiCole A Finch; Heather Flynn; Jennifer Adamson; Naomi Kouri; Aleksandra Wojtas; Pheth Sengdy; Ging-Yuek R Hsiung; Anna Karydas; William W Seeley; Keith A Josephs; Giovanni Coppola; Daniel H Geschwind; Zbigniew K Wszolek; Howard Feldman; David S Knopman; Ronald C Petersen; Bruce L Miller; Dennis W Dickson; Kevin B Boylan; Neill R Graff-Radford; Rosa Rademakers
Journal:  Neuron       Date:  2011-09-21       Impact factor: 17.173

Review 3.  Advances in understanding the molecular basis of frontotemporal dementia.

Authors:  Rosa Rademakers; Manuela Neumann; Ian R Mackenzie
Journal:  Nat Rev Neurol       Date:  2012-06-26       Impact factor: 42.937

4.  Frontotemporal Dementia and Psychiatric Illness: Emerging Clinical and Biological Links in Gene Carriers.

Authors:  Nikolas R Block; Sharon J Sha; Anna M Karydas; Jamie C Fong; Mary G De May; Bruce L Miller; Howard J Rosen
Journal:  Am J Geriatr Psychiatry       Date:  2015-06-21       Impact factor: 4.105

5.  Structure dissection of zebrafish progranulins identifies a well-folded granulin/epithelin module protein with pro-cell survival activities.

Authors:  Ping Wang; Babykumari Chitramuthu; Andrew Bateman; Hugh P J Bennett; Ping Xu; Feng Ni
Journal:  Protein Sci       Date:  2018-07-18       Impact factor: 6.725

Review 6.  Human genetics as a tool to identify progranulin regulators.

Authors:  Alexandra M Nicholson; NiCole A Finch; Rosa Rademakers
Journal:  J Mol Neurosci       Date:  2011-05-28       Impact factor: 3.444

7.  Tunicamycin produces TDP-43 cytoplasmic inclusions in cultured brain organotypic slices.

Authors:  Cadman Leggett; Daniel S McGehee; James Mastrianni; Wenbin Yang; Tao Bai; James R Brorson
Journal:  J Neurol Sci       Date:  2012-03-28       Impact factor: 3.181

8.  Progranulin Deficiency Reduces CDK4/6/pRb Activation and Survival of Human Neuroblastoma SH-SY5Y Cells.

Authors:  Ana de la Encarnación; Carolina Alquézar; Noemí Esteras; Ángeles Martín-Requero
Journal:  Mol Neurobiol       Date:  2014-11-07       Impact factor: 5.590

9.  Circulating progranulin as a biomarker for neurodegenerative diseases.

Authors:  Roberta Ghidoni; Anna Paterlini; Luisa Benussi
Journal:  Am J Neurodegener Dis       Date:  2012-08-02

Review 10.  Progranulin: an emerging target for FTLD therapies.

Authors:  Jennifer Gass; Mercedes Prudencio; Caroline Stetler; Leonard Petrucelli
Journal:  Brain Res       Date:  2012-01-28       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.